Increased mortality with intensive control in patients with higher baseline SBP and lower Framingham risk

HENG-YU PANHUNG-JU LINWEN-JONE CHENTZUNG-DAU WANG2022-08-052022-08-0520220263-6352https://scholars.lib.ntu.edu.tw/handle/123456789/616187In the Systolic Blood Pressure Intervention Trial (SPRINT), the relative reduction in primary outcome with intensive blood pressure (BP) control was numerically smallest in the highest baseline SBP tertile. In this post hoc analysis of SPRINT, the goal was to explore whether the effects of intensive BP treatment varied among patients with different baseline SBP and cardiovascular risks.enantihypertensive agents; blood pressure; cardiovascular diseases; goals; humans; risk factors; BLOOD-PRESSURE PARAMETERS; CARDIOVASCULAR OUTCOMES; HYPERTENSIVE PATIENTS; HEART-FAILURE; MANAGEMENT; SOCIETY; DISEASE; TAIWAN; ADULTS; RANGE[SDGs]SDG3Increased mortality with intensive control in patients with higher baseline SBP and lower Framingham riskjournal article10.1097/HJH.0000000000003100351320392-s2.0-85129996619WOS:000790168600019